Tizanidine 76420-0886-21
- Manufacturer
- Asclemed Usa, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 4, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA208187
Need to source Tizanidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tizanidine Hydrochloride | 4 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Selected Package
76420-0886-21Selected150 TABLET in 1 BOTTLE (76420-886-21)
Other packages for this product(10)
1000 TABLET in 1 BOTTLE (76420-886-00)
100 TABLET in 1 BOTTLE (76420-886-01)
300 TABLET in 1 BOTTLE (76420-886-03)
10 TABLET in 1 BLISTER PACK (76420-886-11)
15 TABLET in 1 BOTTLE (76420-886-15)
30 TABLET in 1 BOTTLE (76420-886-30)
60 TABLET in 1 BOTTLE (76420-886-60)
10 TABLET in 1 BOTTLE (76420-886-88)
90 TABLET in 1 BOTTLE (76420-886-90)
10 BLISTER PACK in 1 CARTON (76420-886-99) / 10 TABLET in 1 BLISTER PACK